Difference between revisions of "Minutes - Medication WG 2021-06-08"

From Health Level 7 Belgium Wiki
 
(6 intermediate revisions by the same user not shown)
Line 3: Line 3:
 
* Annemieke Vergauwe  
 
* Annemieke Vergauwe  
 
* Bruno Casneuf
 
* Bruno Casneuf
* Elhassan Baazizi
 
* Jan Lenie
 
 
* Jean-Michel Polfliet
 
* Jean-Michel Polfliet
 
* José Costa Teixeira  
 
* José Costa Teixeira  
 +
* Katrien Thorré
 
* Karlien Erauw  
 
* Karlien Erauw  
 
* Nick Hermans
 
* Nick Hermans
 
* Pablo Christiaens
 
* Pablo Christiaens
 +
* Richard Francken
 
* Robin Bosman
 
* Robin Bosman
 
* Thomas Van Langendonck
 
* Thomas Van Langendonck
Line 16: Line 16:
  
 
===== '''Excused/Not present''' =====
 
===== '''Excused/Not present''' =====
 
 
* Dieter Sauvillers
 
* Dieter Sauvillers
 +
* Elhassan Baazizi
 
* Hanne Vuegen
 
* Hanne Vuegen
 +
* Jan Lenie
 
* Jean-Louis Maggetto  
 
* Jean-Louis Maggetto  
 
* Jens Penny
 
* Jens Penny
Line 33: Line 34:
  
 
===== '''Minutes''' =====
 
===== '''Minutes''' =====
* feedback on the workshop
+
* Magistral
 +
* FAGG has sent us through RIZIV a [https://drive.google.com/file/d/1QjyHgY77UhKN6vlpx6FEErTp4NoqKkef/view?usp=sharing mapping SAMv1 to SAMv2], that was sent to all WG-members last week
 +
::* please collect feedback in your team and send it by email to [http://mailto:karlien.erauw@agoria.be Karlien]
 +
feedback on the FHIR medication workshop that took place with a couple of WG-members last week
 
::* “Stofnaam” aka “Substance” should be changed by VOS-cluster. Under a VOS-cluster we understand the following:
 
::* “Stofnaam” aka “Substance” should be changed by VOS-cluster. Under a VOS-cluster we understand the following:
 
::::* Same substance(s)
 
::::* Same substance(s)
Line 46: Line 50:
 
::::* different VMP's are grouped in a cluster code, same administration code, not form of administration (disrriminiation of syrop vs pills is done through strength)
 
::::* different VMP's are grouped in a cluster code, same administration code, not form of administration (disrriminiation of syrop vs pills is done through strength)
  
 
+
* During the workshop 12 scenario's have been defined:
* 12 scenario's have been defined
 
 
::* Prescribed branded medication is changed by another branded medication from the same VOS-cluster
 
::* Prescribed branded medication is changed by another branded medication from the same VOS-cluster
 
::* Prescribed medication is changed by another medication from a different VOS-cluster
 
::* Prescribed medication is changed by another medication from a different VOS-cluster
Line 55: Line 58:
 
::::* e.g. stomach protector that is delivered to the patient
 
::::* e.g. stomach protector that is delivered to the patient
 
::* Dispense of prescribed medication, and dispense of a product that can be done without a prescription
 
::* Dispense of prescribed medication, and dispense of a product that can be done without a prescription
::* Dispense of new brand medication that is given because the old is unavailable, so giving to continu the cure and not to replace it
+
::* Dispense of new brand medication that is given because the old is unavailable, so giving to continue the cure and not to replace it
 
::* Refuse the dispense prescribed medication
 
::* Refuse the dispense prescribed medication
 
::* Dispense of medication that was prescribed, but not taken
 
::* Dispense of medication that was prescribed, but not taken
Line 76: Line 79:
 
::::* patient is admitted, hospital takes over the medication from the scheme
 
::::* patient is admitted, hospital takes over the medication from the scheme
 
::::* patient is discharged, hospital reconciles the medication that was used with the medication scheme
 
::::* patient is discharged, hospital reconciles the medication that was used with the medication scheme
 +
 +
* Do we have to extend the model to include individual prescriptions ?
 +
::* is the posology already sufficient as it is now in the model ?
 +
::* the regimen exists today and the model should foresee something similar
 +
::* for the pharmacist the time b/w the different intakes and with or without food is important
 +
::* José will be working on a use case for this
 +
 +
* Swiss approach of medication treatment plan
 +
::* doctor starts a medication treatment plan and everything afterwards is part of this plan
 +
::* Swiss documentation:
 +
::::* [https://www.e-health-suisse.ch/fileadmin/user_upload/Dokumente/E/report-emedication-architecture-epr-summary.pdf Summary]
 +
::::* [https://www.e-health-suisse.ch/fileadmin/user_upload/Dokumente/E/Implementation_Guide_eMedication_Architecture_Specs_013_Anhoerung.pdf Detailed specifications v0.13]
 +
::* In Belgium now we only have prescriptions, we don't have a starting point
 +
::* often a doctor starts with a prescription without it being part of a fixed plan (try-out)
 +
::* a medication can be part of multiple treatment plans
 +
::* this starting point (medication plan) does not seem to be mandatory, it can be optional
 +
::* Can we have a look at the Swiss documents and check what is useful for us (f.e. use cases)
  
 
'''Action items for next meeting'''
 
'''Action items for next meeting'''
::* review of the examples
+
::* José will work on a posology use case
 +
::* Review of Swiss documents
  
 
'''Next meeting June 22 at 11AM'''
 
'''Next meeting June 22 at 11AM'''

Latest revision as of 10:15, 8 June 2021

Attendees
  • Anne Nerenhausen
  • Annemieke Vergauwe
  • Bruno Casneuf
  • Jean-Michel Polfliet
  • José Costa Teixeira
  • Katrien Thorré
  • Karlien Erauw
  • Nick Hermans
  • Pablo Christiaens
  • Richard Francken
  • Robin Bosman
  • Thomas Van Langendonck
  • Tom De Backer
  • Tom Henkens
Excused/Not present
  • Dieter Sauvillers
  • Elhassan Baazizi
  • Hanne Vuegen
  • Jan Lenie
  • Jean-Louis Maggetto
  • Jens Penny
  • Jeroen De Wilde
  • Lars Vanreppelen
  • Marc Buckens
  • Nils Devos
  • Richard Francken
  • Will van Norel
Agenda
  • review of SAMv1 to SAMv2 mapping
  • review of the examples
Minutes
  • please collect feedback in your team and send it by email to Karlien
  • feedback on the FHIR medication workshop that took place with a couple of WG-members last week
  • “Stofnaam” aka “Substance” should be changed by VOS-cluster. Under a VOS-cluster we understand the following:
  • Same substance(s)
  • Same strength
  • Comparable package size
  • Form of administration
  • Additional info:
  • to check: Contramal 100 mg vs Contramal 100 mg retard
  • comparable package sizes are not packaged in Belgium (was under discussion once)
  • different VMP's are grouped in a cluster code, same administration code, not form of administration (disrriminiation of syrop vs pills is done through strength)
  • During the workshop 12 scenario's have been defined:
  • Prescribed branded medication is changed by another branded medication from the same VOS-cluster
  • Prescribed medication is changed by another medication from a different VOS-cluster
  • Different strength, different package size or different form of administration is dispensed
  • Different substance(s) is dispensed
  • Dispense medication before the prescription of the general practitioner
  • e.g. stomach protector that is delivered to the patient
  • Dispense of prescribed medication, and dispense of a product that can be done without a prescription
  • Dispense of new brand medication that is given because the old is unavailable, so giving to continue the cure and not to replace it
  • Refuse the dispense prescribed medication
  • Dispense of medication that was prescribed, but not taken
  • e.g. an antibiotic that is prescribed when doing international travel as a safeguard
  • Dispense of medication that was prescribed, but not taken till the end
  • e.g. an antibiotic that is prescribed but when using the patient had an allergic reaction
  • might be connected to scenario 3, when the pharmacist gives an alternative
  • The recording of anesthetic, contrast and similar medications in the medication scheme
  • The recording of non-medication aka pharmaceutical products
  • Food supplement
  • Sunscreen
  • ...
  • The view and/or filters for
  • a GP
  • a nurse / caretaker
  • a pharmacist
  • a specialist
  • a patient
  • The patient is admitted to hospital and there the medication is changed to better help the patient.
  • patient is admitted, hospital takes over the medication from the scheme
  • patient is discharged, hospital reconciles the medication that was used with the medication scheme
  • Do we have to extend the model to include individual prescriptions ?
  • is the posology already sufficient as it is now in the model ?
  • the regimen exists today and the model should foresee something similar
  • for the pharmacist the time b/w the different intakes and with or without food is important
  • José will be working on a use case for this
  • Swiss approach of medication treatment plan
  • doctor starts a medication treatment plan and everything afterwards is part of this plan
  • Swiss documentation:
  • In Belgium now we only have prescriptions, we don't have a starting point
  • often a doctor starts with a prescription without it being part of a fixed plan (try-out)
  • a medication can be part of multiple treatment plans
  • this starting point (medication plan) does not seem to be mandatory, it can be optional
  • Can we have a look at the Swiss documents and check what is useful for us (f.e. use cases)

Action items for next meeting

  • José will work on a posology use case
  • Review of Swiss documents

Next meeting June 22 at 11AM